Immunopathology and Laboratory Diagnosis of Rheumatoid Arthritis: A Review of Literature

Vol 8 No 7 (2025): Volume 08 Issue 07 July 2025

Article Date Published : 5 July 2025 | Page No.: 3231-3245 | Google Scholar | Crossref doi for this article

Abstract :

This review explores rheumatoid arthritis, an autoimmune disorder whose immunopathology involves a convergence of genetic susceptibility (notably HLA-DRB1 shared epitope alleles) and environmental exposures (smoking, infections) leading to an aberrant immune response. RA is a prevalent autoimmune disease globally, and though historically considered uncommon in Africa, emerging data show it is an important and likely under-recognized health issue in regions like Nigeria. Epidemiologically, ~0.5% of the world’s population is affected with millions suffering chronic pain and disability. In Africa and Southeastern Nigeria, true prevalence is uncertain due to diagnostic gaps, but RA cases are increasingly reported as awareness grows. Autoimmune processes – generation of RF and ACPA autoantibodies, activation of T cells and macrophages, and a cytokine-driven inflammation – result in synovial damage and systemic effects. Understanding these mechanisms explains why specific biomarkers (RF, ACPA) are useful in diagnosis and why therapies targeting cytokines (like TNF or IL-6 inhibitors) are effective. In laboratory diagnosis, we identified the core tools: RF and ACPA testing for confirming autoantibodies, ESR and CRP for gauging inflammation, and newer panels for disease activity. In resource-constrained settings, basic assays can be performed with relatively low-cost methods (e.g. ESR by Westergren, RF by latex agglutination), but introducing more specific tests like anti-CCP is vital for improving diagnostic specificity. We provided practical outlines for these assays, emphasizing adherence to SOPs and quality control to ensure accuracy of results.

Keywords :

Anti-Citrullinated Protein Antibodies, Autoantibody., Autoimmune disease, Biomarkers, cytokines, environmental factors., Genetic factors, Inflammation, Rheumatoid arthritis., Rheumatoid Factor

References :

  1. Adelowo, O., Mody, G. M., Tikly, M., Oyoo, O., & Slimani, S. (2021). Rheumatic diseases in Africa. Nature reviews. Rheumatology, 17(6), 363–374. https://doi.org/10.1038/s41584-021-00603-4
  2. Aggarwal, R., Liao, K., Nair, R., Ringold, S., & Costenbader, K. H. (2009). Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis and Rheumatism, 61(11), 1472–1483. https://doi.org/10.1002/art.24827
  3. Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., 3rd, Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., Combe, B., Costenbader, K. H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M., Hobbs, K., Huizinga, T. W., Kavanaugh, A., Kay, J., … Hawker, G. (2010). 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases, 69(9), 1580–1588. https://doi.org/10.1136/ard.2010.138461
  4. AlGhalawin, L. S., Alomar, M., Al Bassam, S., AlHamdan, A. A., Anan, H., Altaweel, M., Alomran, Z. A., Al Khamis, R., Alqatri, A. I., Alamoudi, M. M., & Alamer, A. (2024). Incidence Rate of Cardiovascular Events in Rheumatoid Arthritis: An Observational Cohort Study in Saudi Arabia. Journal of Multidisciplinary Healthcare, 17, 3357–3370. https://doi.org/10.2147/JMDH.S459555
  5. Alivernini, S., Firestein, G.S., McInnes, I.B. (2022). The pathogenesis of rheumatoid arthritis. Immunity, 55(12), 2255-2270. https://doi.org/1016/j.immuni.2022.11.009
  6. Alivernini, S., Masserdotti, A., Magatti, M., Cargnoni, A., Papait, A., Silini, A. R., Romoli, J., Ficai, S., Di Mario, C., Gremese, E., Tolusso, B., & Parolini, O. (2024). Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis. Heliyon, 11(1), e41438. https://doi.org/10.1016/j.heliyon.2024.e41438
  7. Almoallim, H., Al Saleh, J., Badsha, H., Ahmed, H. M., Habjoka, S., Menassa, J. A., & El-Garf, A. (2021). A Review of the Prevalence and Unmet Needs in the Management of Rheumatoid Arthritis in Africa and the Middle East. Rheumatology and Therapy, 8(1), 1–16. https://doi.org/10.1007/s40744-020-00252-1
  8. Almutairi, K., Nossent, J., Preen, D., Keen, H., & Inderjeeth, C. (2021). The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatology International, 41(5), 863–877. https://doi.org/10.1007/s00296-020-04731-0
  9. Avina-Zubieta, J. A., Thomas, J., Sadatsafavi, M., Lehman, A. J., & Lacaille, D. (2012). Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Annals of the Rheumatic Diseases, 71(9), 1524–1529. https://doi.org/10.1136/annrheumdis-2011-200726
  10. Azam, A. T., Odeyinka, O., Alhashimi, R., Thoota, S., Ashok, T., Palyam, V., & Sange, I. (2022). Rheumatoid Arthritis and Associated Lung Diseases: A Comprehensive Review. Cureus, 14(2), e22367. https://doi.org/10.7759/cureus.22367
  11. Bačenková, D., Trebuňová, M., Morochovič, R., Dosedla, E., Findrik Balogová, A., Gašparová, P., & Živčák, J. (2022). Interaction between Mesenchymal Stem Cells and the Immune System in Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland), 15(8), 941. https://doi.org/10.3390/ph15080941
  12. Bakker, M. F., Cavet, G., Jacobs, J. W., Bijlsma, J. W., Haney, D. J., Shen, Y., Hesterberg, L. K., Smith, D. R., Centola, M., van Roon, J. A., Lafeber, F. P., & Welsing, P. M. (2012). Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Annals of the Rheumatic Diseases, 71(10), 1692–1697. https://doi.org/10.1136/annrheumdis-2011-200963
  13. Bartels, C.M., & Bridges, A.J. (2010). Rheumatoid vasculitis: vanishing menace or target for new treatments? Current Rheumatology Reports, 12(6), 414-9. https://doi.org/10.1007/s11926-010-0130-1
  14. Bhattacharya, D., Theodoropoulos, J., Nurmi, K., Juutilainen, T., Eklund, K. K., Koivuniemi, R., Kelkka, T., Mustjoki, S., & Lönnberg, T. (2024). Single-cell characterisation of tissue homing CD4 + and CD8 + T cell clones in immune-mediated refractory arthritis. Molecular Medicine (Cambridge, Mass.), 30(1), 48. https://doi.org/10.1186/s10020-024-00802-1
  15. Cadório, M. J., Teixeira, J., Oliveira, J., Santiago, T., Gonçalo, M., & Duarte, C. (2024). Beyond rheumatoid nodules in rheumatoid arthritis. Beyond rheumatoid nodules in rheumatoid arthritis. ARP Rheumatology, 3(3), 240–242. https://doi.org/10.63032/VLZL5564
  16. Catrina, A., Krishnamurthy, A., & Rethi, B. (2021). Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis. RMD open, 7(1), e001228. https://doi.org/10.1136/rmdopen-2020-001228
  17. Chemin, K., Gerstner, C., & Malmström, V. (2019). Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis. Frontiers in Immunology, 10, 353. https://doi.org/10.3389/fimmu.2019.00353
  18. Cheng, Z., Meade, J., Mankia, K., Emery, P., & Devine, D. A. (2017). Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology, 31(1), 19–30. https://doi.org/10.1016/j.berh.2017.08.001
  19. Ciofoaia, E. I., Pillarisetty, A., & Constantinescu, F. (2022). Health disparities in rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease, 14, 1759720X221137127. https://doi.org/10.1177/1759720X221137127
  20. Cojocaru, M., Cojocaru, I. M., Silosi, I., Vrabie, C. D., & Tanasescu, R. (2010). Extra-articular Manifestations in Rheumatoid Arthritis. Maedica, 5(4), 286–291.
  21. Conforti, A., Di Cola, I., Pavlych, V., Ruscitti, P., Berardicurti, O., Ursini, F., Giacomelli, R., & Cipriani, P. (2021). Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmunity Reviews, 20(2), 102735. https://doi.org/10.1016/j.autrev.2020.102735
  22. de Souza, S.M.P., Alves, T.S.G.N., da Silva, A.F.S.F., Hatem, M.A.B., de Oliveira, I.S., Laporte, L.R., Nogueira, C.N.D., Ferreira, L.G.A., Santiago, M.B. (2024). Lung involvement in rheumatoid arthritis: what do we know?. Discover Medicine, 1, 137. https://doi.org/10.1007/s44337-024-00165-w
  23. Deane, K. D., Demoruelle, M. K., Kelmenson, L. B., Kuhn, K. A., Norris, J. M., & Holers, V. M. (2017). Genetic and environmental risk factors for rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology, 31(1), 3–18. https://doi.org/10.1016/j.berh.2017.08.003
  24. Demoruelle, M.K. (2019). Mucosa Biology and the Development of Rheumatoid Arthritis: Potential for Prevention by Targeting Mucosal Processes. Clinical Therapeutics, 41(7), 1270-1278. https://doi.org/10.1016/j.clinthera.2019.04.012
  25. Dort, J., Fabre, P., Molina, T., & Dumont, N. A. (2019). Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases. Stem Cells International, 2019, 4761427. https://doi.org/10.1155/2019/4761427
  26. GBD 2019 Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
  27. GBD 2021 Rheumatoid Arthritis Collaborators (2023). Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet. Rheumatology, 5(10), e594–e610. https://doi.org/10.1016/S2665-9913(23)00211-4
  28. Ge, C., Weisse, S., Xu, B., Dobritzsch, D., Viljanen, J., Kihlberg, J., Do, N. N., Schneider, N., Lanig, H., Holmdahl, R., & Burkhardt, H. (2022). Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor. Annals of the Rheumatic Diseases, 81(4), 480–489. https://doi.org/10.1136/annrheumdis-2021-220500
  29. Gerena, L.A., Mabrouk, A., & DeCastro, A. (2024). Knee Effusion. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532279/
  30. Gregory, A., Kliment, C., Thiele, G., Duryee, M., Mikuls, T., England, B., Poole, J., Ascherman, D. (2021). Cigarette Smoking Induces Post-translational Protein Modifications in Both in Vitro and in Vivo Models of Rheumatoid Arthritis-associated Interstitial Lung Disease [abstract]. Arthritis Rheumatology, 73 (suppl 9). https://acrabstracts.org/abstract/cigarette-smoking-induces-post-translational-protein-modifications-in-both-in-vitro-and-in-vivo-models-of-rheumatoid-arthritis-associated-interstitial-lung-disease/. Accessed June 22, 2025.
  31. Guan, M., Yu, Q., Zhou, G., Wang, Y., Yu, J., Yang, W., & Li, Z. (2024). Mechanisms of chondrocyte cell death in osteoarthritis: implications for disease progression and treatment. Journal of Orthopaedic Surgery and Research, 19(1), 550. https://doi.org/10.1186/s13018-024-05055-6
  32. Haro, I., Castellanos-Moreira, R., Sanmartí, R., & Gómara, M. J. (2024). Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides. Diagnostics (Basel, Switzerland), 14(22), 2485. https://doi.org/10.3390/diagnostics14222485
  33. Hedström, A. K., Stawiarz, L., Klareskog, L., & Alfredsson, L. (2018). Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study. European Journal of Epidemiology, 33(4), 415–423. https://doi.org/10.1007/s10654-018-0360-5
  34. Holers, V. M., Demoruelle, M. K., Kuhn, K. A., Buckner, J. H., Robinson, W. H., Okamoto, Y., Norris, J. M., & Deane, K. D. (2018). Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nature Reviews. Rheumatology, 14(9), 542–557. https://doi.org/10.1038/s41584-018-0070-0
  35. Hu, X., Li, J., Fu, M., Zhao, X., & Wang, W. (2021). The JAK/STAT signaling pathway: from bench to clinic. Signal Transduction and Targeted Therapy, 6(1), 402. https://doi.org/10.1038/s41392-021-00791-1
  36. Huang, R., Zhang, M., Lu, Y., Xu, D., Liu, Y., Jin, M., Xian, S., Wang, S., Tong, X., Lu, J., Zhang, W., Qian, W., Tang, J., Yang, Y., Lu, B., Chang, Z., Liu, X., & Ji, S. (2023). Effects of intestinal microbes on rheumatic diseases: A bibliometric analysis. Frontiers in Microbiology, 13, 1074003. https://doi.org/10.3389/fmicb.2022.1074003
  37. Hughes, L. B., Morrison, D., Kelley, J. M., Padilla, M. A., Vaughan, L. K., Westfall, A. O., Dwivedi, H., Mikuls, T. R., Holers, V. M., Parrish, L. A., Alarcón, G. S., Conn, D. L., Jonas, B. L., Callahan, L. F., Smith, E. A., Gilkeson, G. S., Howard, G., Moreland, L. W., Patterson, N., Reich, D., … Bridges, S. L., Jr (2008). The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis and Rheumatism, 58(2), 349–358. https://doi.org/10.1002/art.23166
  38. Ishikawa, Y., & Terao, C. (2020). The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells, 9(2), 475. https://doi.org/10.3390/cells9020475
  39. Jajoo, N.S., Shelke, A.U., Bajaj, R.S., & Devani V. (2021). Correction to: Periodontitis and Rheumatoid Arthritis: The Common Thread. Clinical Reviews in Bone and Mineral Metabolism 19, 50–62. https://doi.org/10.1007/s12018-021-09280-z
  40. Jiang, X., & Alfredsson, L. (2020). Modifiable environmental exposure and risk of rheumatoid arthritis—current evidence from genetic studies. Arthritis Research and Therapy, 22, 154. https://doi.org/10.1186/s13075-020-02253-5
  41. Joshua, V., Loberg Haarhaus, M., Hensvold, A., Wähämaa, H., Gerstner, C., Hansson, M., Israelsson, L., Stålesen, R., Sköld, M., Grunewald, J., Klareskog, L., Grönwall, C., Réthi, B., Catrina, A. and Malmström, V. (2023), Rheumatoid Arthritis–Specific Autoimmunity in the Lung Before and at the Onset of Disease. Arthritis Rheumatology, 75, 1910-1922. https://doi.org/10.1002/art.42549
  42. Jurgens, M. S., Safy-Khan, M., de Hair, M. J. H., Bijlsma, J. W. J., Welsing, P. M. J., Tekstra, J., Lafeber, F. P. J. G., Sasso, E. H., Jacobs, J. W. G., & Society for Rheumatology research Utrecht (2020). The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial. Arthritis Research & Therapy, 22(1), 205. https://doi.org/10.1186/s13075-020-02293-x
  43. Khodadust, F., Ezdoglian, A., Steinz, M. M., van Beijnum, J. R., Zwezerijnen, G. J. C., Jansen, G., Tas, S. W., & van der Laken, C. J. (2022). Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis. International Journal of Molecular Sciences, 23(13), 7071. https://doi.org/10.3390/ijms23137071
  44. Kolou, M. (2023). Challenges of Rheumatoid Arthritis Management in Sub-Saharan Africa in the 21st Century. Open Journal of Rheumatology and Autoimmune Diseases, 13, 17-40. https://doi.org/10.4236/ojra.2023.131003
  45. Kondo, N., Kuroda, T., & Kobayashi, D. (2021). Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis. International Journal of Molecular Sciences, 22(20), 10922. https://doi.org/10.3390/ijms222010922
  46. Kotulska, A., Kopeć-Mędrek, M., Grosicka, A., Kubicka, M., & Kucharz, E. J. (2015). Correlation between erythrocyte sedimentation rate and C-reactive protein level in patients with rheumatic diseases. Reumatologia, 53(5), 243–246. https://doi.org/10.5114/reum.2015.55825
  47. Kumar, A., Vasdev, V., Patnaik, S. K., Bhatt, S., Singh, R., Bhayana, A., Hegde, A., & Kumar, A. (2022). The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population. Medical Journal, Armed Forces India, 78(Suppl 1), S69–S74. https://doi.org/10.1016/j.mjafi.2020.04.007
  48. Kurowska, W., Kuca-Warnawin, E. H., Radzikowska, A., & Maśliński, W. (2017). The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Central-European Journal of Immunology, 42(4), 390–398. https://doi.org/10.5114/ceji.2017.72807
  49. Laria, A., Lurati, A. M., Zizzo, G., Zaccara, E., Mazzocchi, D., Re, K. A., Marrazza, M., Faggioli, P., & Mazzone, A. (2022). Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review. Frontiers in Medicine, 9, 837133. https://doi.org/10.3389/fmed.2022.837133
  50. Law, S. C., Street, S., Yu, C. H., Capini, C., Ramnoruth, S., Nel, H. J., van Gorp, E., Hyde, C., Lau, K., Pahau, H., Purcell, A. W., & Thomas, R. (2012). T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Research & Therapy, 14(3), R118. https://doi.org/10.1186/ar3848
  51. Liu, J., Gao, J., Wu, Z., Mi, L., Li, N., Wang, Y., Peng, X., Xu, K., Wu, F., & Zhang, L. (2022). Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects. Frontiers in Medicine, 8, 802934. https://doi.org/10.3389/fmed.2021.802934
  52. Lucchino, B., Spinelli, F. R., Iannuccelli, C., Guzzo, M. P., Conti, F., & Di Franco, M. (2019). Mucosa-Environment Interactions in the Pathogenesis of Rheumatoid Arthritis. Cells, 8(7), 700. https://doi.org/10.3390/cells8070700
  53. Lv, Y., Qi, J., Babon, J. J., Cao, L., Fan, G., Lang, J., Zhang, J., Mi, P., Kobe, B., & Wang, F. (2024). The JAK-STAT pathway: from structural biology to cytokine engineering. Signal Transduction and Targeted Therapy, 9(1), 221. https://doi.org/10.1038/s41392-024-01934-w
  54. Ma, Y., Chen, H., Lv, W., Wei, S., Zou, Y., Li, R., Wang, J., She, W., Yuan, L., Tao, J., Guo, X., Bi, S., Tian, H., Ma, Y., Sun, H., Sun, C., Xu, J., Dong, Y., Kang, J., Lv, H., … Jiang, Y. (2025). Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021. Biomarker Research, 13(1), 47. https://doi.org/10.1186/s40364-025-00760-8
  55. Maggi, L., Mazzoni, A., Cimaz, R., Liotta, F., Annunziato, F., & Cosmi, L. (2019). Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis. Frontiers in Immunology, 10, 450. https://doi.org/10.3389/fimmu.2019.00450
  56. Malmström, V., Catrina, A. I., & Klareskog, L. (2017). The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nature Reviews. Immunology, 17(1), 60–75. https://doi.org/10.1038/nri.2016.124
  57. Matsushima, K., Yang, D., & Oppenheim, J. J. (2022). Interleukin-8: An evolving chemokine. Cytokine, 153, 155828. https://doi.org/10.1016/j.cyto.2022.155828
  58. Mehri, F., Jenabi, E., Bashirian, S., Shahna, F. G., & Khazaei, S. (2020). The association Between Occupational Exposure to silica and Risk of Developing Rheumatoid Arthritis: A Meta-Analysis. Safety and Health at Work, 11(2), 136–142. https://doi.org/10.1016/j.shaw.2020.02.001
  59. Mills K. H. G. (2023). IL-17 and IL-17-producing cells in protection versus pathology. Nature Reviews. Immunology, 23(1), 38–54. https://doi.org/10.1038/s41577-022-00746-9
  60. Min, Y. S., Kim, M. G., & Ahn, Y. S. (2021). Rheumatoid Arthritis in Silica-Exposed Workers. International Journal of Environmental Research and Public Health, 18(23), 12776. https://doi.org/10.3390/ijerph182312776
  61. Modak, D., Bhattacharjee, S. (2022). A review of fibroblast-like synoviocytes in the pathogenesis of Rheumatoid arthritis: Their activation and the inhibition of their apoptosis. Biomedical Research and Therapy, 9(11), 5394-5409.
  62. Myasoedova, E., Crowson, C. S., Kremers, H. M., Therneau, T.M., & Gabriel, S. E. (2010). Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis and Rheumatism, 62(6), 1576–1582. https://doi.org/10.1002/art.27425
  63. Narváez J. (2024). Moving forward in Rheumatoid Arthritis-Associated Interstitial Lung Disease Screening. Journal of Clinical Medicine, 13(18), 5385. https://doi.org/10.3390/jcm13185385
  64. Nemtsova, M. V., Zaletaev, D. V., Bure, I. V., Mikhaylenko, D. S., Kuznetsova, E. B., Alekseeva, E. A., Beloukhova, M. I., Deviatkin, A. A., Lukashev, A. N., & Zamyatnin, A. A., Jr (2019). Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis. Frontiers in Genetics, 10, 570. https://doi.org/10.3389/fgene.2019.00570
  65. Nicolò, A., Amendt, T., El Ayoubi, O., Young, M., Finzel, S., Senel, M., Voll, R. E., & Jumaa, H. (2022). Rheumatoid factor IgM autoantibodies control IgG homeostasis. Frontiers in Immunology, 13, 1016263. https://doi.org/10.3389/fimmu.2022.1016263
  66. Nishimura, K., Sugiyama, D., Kogata, Y., Tsuji, G., Nakazawa, T., Kawano, S., Saigo, K., Morinobu, A., Koshiba, M., Kuntz, K. M., Kamae, I., & Kumagai, S. (2007). Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of Internal Medicine, 146(11), 797–808. https://doi.org/10.7326/0003-4819-146-11-200706050-00008
  67. Niu, Q., Gao, J., Wang, L., Liu, J., & Zhang, L. (2022). Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis. Frontiers in Immunology, 13, 1034050. https://doi.org/10.3389/fimmu.2022.1034050
  68. Oliveira, V. D. R. S., Reis, A. P. M. G., Brenol, C. V., Pereira, I. A., Bonfiglioli, K. R., Pereira, L. R., Bértolo, M. B., de Fátima L C Sauma, M., Guimarães, M. F. B. R., Louzada-Júnior, P., Giorgi, R. D. N., Radominski, S. C., Mota, L. M. H., Albuquerque, C. P., & Castelar-Pinheiro, G. R. (2025). High-Titer Rheumatoid Factor is Associated with Worse Clinical Outcomes and Higher Needs for Advanced Therapies in Rheumatoid Arthritis Under Real-Life Conditions. Rheumatology and Therapy, 12(1), 123–136. https://doi.org/10.1007/s40744-024-00730-w
  69. Onuora, S. (2025). Profiling synovial tissue reveals OA subgroups. Nature Reviews Rheumatology, 21, 256. https://doi.org/10.1038/s41584-025-01241-w
  70. Orr, C. K., Najm, A., Young, F., McGarry, T., Biniecka, M., Fearon, U., & Veale, D. J. (2018). The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis. Frontiers in Medicine, 5, 185. https://doi.org/10.3389/fmed.2018.00185
  71. Özkan, U., Kakilli, N., Gürdoğan, M., Taştekin, N., & Birtane, M. (2023). Rheumatoid arthritis and cardiovascular comorbidities. Exploration of Musculoskeletal Diseases, 1, 264–88. https://doi.org/10.37349/emd.2023.00028
  72. Pianta, A., Arvikar, S., Strle, K., Drouin, E. E., Wang, Q., Costello, C. E., & Steere, A. C. (2017). Evidence of the Immune Relevance of Prevotella copri, a Gut Microbe, in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.), 69(5), 964–975. https://doi.org/10.1002/art.40003
  73. Rajasekaran, J. J., Krishnamurthy, H. K., Bosco, J., Jayaraman, V., Krishna, K., Wang, T., & Bei, K. (2024). Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. Microorganisms, 12(9), 1797. https://doi.org/10.3390/microorganisms12091797
  74. Ridgley, L. A., Anderson, A. E., & Pratt, A. G. (2018). What are the dominant cytokines in early rheumatoid arthritis?. Current Opinion in Rheumatology, 30(2), 207–214. https://doi.org/10.1097/BOR.0000000000000470
  75. Romão, V. C., & Fonseca, J. E. (2022). Disease mechanisms in preclinical rheumatoid arthritis: A narrative review. Frontiers in Medicine, 9, 689711. https://doi.org/10.3389/fmed.2022.689711
  76. Roos Ljungberg, K., Börjesson, E., Martinsson, K., Wetterö, J., Kastbom, A., & Svärd, A. (2020). Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22(1), 274. https://doi.org/10.1186/s13075-020-02363-0
  77. Seidman, A.J., & Limaiem, F. (2023). Synovial Fluid Analysis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537114/
  78. Sharma, S. D., Leung, S. H., & Viatte, S. (2024). Genetics of rheumatoid arthritis. Best practice & research. Clinical Rheumatology, 38(4), 101968. https://doi.org/10.1016/j.berh.2024.101968
  79. Sherina, N., de Vries, C., Kharlamova, N., Sippl, N., Jiang, X., Brynedal, B., Kindstedt, E., Hansson, M., Mathsson-Alm, L., Israelsson, L., Stålesen, R., Saevarsdottir, S., Holmdahl, R., Hensvold, A., Johannsen, G., Eriksson, K., Sallusto, F., Catrina, A. I., Rönnelid, J., Grönwall, C., … Lundberg, K. (2022). Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology. Frontiers in Immunology, 13, 804822. https://doi.org/10.3389/fimmu.2022.804822
  80. Sidney, J., Becart, S., Zhou, M., Duffy, K., Lindvall, M., Moore, E. C., Moore, E. L., Rao, T., Rao, N., Nielsen, M., Peters, B., & Sette, A. (2017). Citrullination only infrequently impacts peptide binding to HLA class II MHC. PloS one, 12(5), e0177140. https://doi.org/10.1371/journal.pone.0177140
  81. Silman, A. J., Ollier, W., Holligan, S., Birrell, F., Adebajo, A., Asuzu, M. C., Thomson, W., & Pepper, L. (1993). Absence of rheumatoid arthritis in a rural Nigerian population. The Journal of Rheumatology, 20(4), 618–622.
  82. Steiner, G., Verschueren, P., Van Hoovels, L., Studenic, P., & Bossuyt, X. (2024). Classification of rheumatoid arthritis: is it time to revise the criteria?. RMD open, 10(2), e003851. https://doi.org/10.1136/rmdopen-2023-003851
  83. Su, Q. Y., Li, H. C., Jiang, X. J., Jiang, Z. Q., Zhang, Y., Zhang, H. Y., & Zhang, S. X. (2024). Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 174, 116440. https://doi.org/10.1016/j.biopha.2024.116440
  84. Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023). T cells in health and disease. Signal Transduction and Targeted Therapy, 8(1), 235. https://doi.org/10.1038/s41392-023-01471-y
  85. Sung, W. Y., & Tsai, W. C. (2021). Rethink About the Role of Rheumatoid Factor and Anti-citrullinated Protein Antibody in Rheumatoid Arthritis. Rheumatology and Immunology Research, 2(1), 19–25. https://doi.org/10.2478/rir-2021-0003
  86. Takeuchi, Y., Hirota, K., & Sakaguchi, S. (2019). Synovial Tissue Inflammation Mediated by Autoimmune T Cells. Frontiers in Immunology, 10, 1989. https://doi.org/10.3389/fimmu.2019.01989
  87. Tang, K., Zhu, L., Shan, S., Luo, Z., Zhou, J., Ying, J., Wu, J., Shen, G., & Song, P. (2025). Global, regional and national trends in the epidemiology of rheumatoid arthritis from 1990 to 2021: an age-period-cohort effect analysis of the global burden of disease study 2021. RMD open, 11(2), e005383. https://doi.org/10.1136/rmdopen-2024-005383
  88. Taylor, P. C., Feist, E., Pope, J. E., Nash, P., Sibilia, J., Caporali, R., & Balsa, A. (2024). What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?. Therapeutic Advances in Musculoskeletal Disease, 16, 1759720X241283340. https://doi.org/10.1177/1759720X241283340
  89. Tishkowski, K., Zubair, M. (2023). Erythrocyte Sedimentation Rate. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557485/
  90. Tiwari, V., Jandu, J.S., Bergman, M.J. (2023). Rheumatoid Factor. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532898/
  91. Tizaoui, K., Shin, J. I., Jeong, G. H., Yang, J. W., Park, S., Kim, J. H., Hwang, S. Y., Park, S. J., Koyanagi, A., & Smith, L. (2022). Genetic Polymorphism of PTPN22 in Autoimmune Diseases: A Comprehensive Review. Medicina (Kaunas, Lithuania), 58(8), 1034. https://doi.org/10.3390/medicina58081034
  92. Togashi, T., Ishihara, R., Watanabe, R., Shiomi, M., Yano, Y., Fujisawa, Y., Katsushima, M., Fukumoto, K., Yamada, S., & Hashimoto, M. (2025). Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis. Journal of Clinical Medicine, 14(5), 1529. https://doi.org/10.3390/jcm14051529
  93. Usenbo, A., Kramer, V., Young, T., & Musekiwa, A. (2015). Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis. PloS one, 10(8), e0133858. https://doi.org/10.1371/journal.pone.0133858
  94. van Delft, M. A. M., & Huizinga, T. W. J. (2020). An overview of autoantibodies in rheumatoid arthritis. Journal of Autoimmunity, 110, 102392. https://doi.org/10.1016/j.jaut.2019.102392
  95. van Drongelen, V., & Holoshitz, J. (2017). Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis. Rheumatic Diseases Clinics of North America, 43(3), 363–376. https://doi.org/10.1016/j.rdc.2017.04.003
  96. van Drongelen, V., Scavuzzi, B. M., Nogueira, S. V., Miller, F. W., Sawalha, A. H., & Holoshitz, J. (2021). HLA-DRB1 allelic epitopes that associate with autoimmune disease risk or protection activate reciprocal macrophage polarization. Scientific Reports, 11(1), 2599. https://doi.org/10.1038/s41598-021-82195-3
  97. Venetsanopoulou, A. I., Alamanos, Y., Voulgari, P. V., & Drosos, A. A. (2023). Epidemiology and Risk Factors for Rheumatoid Arthritis Development. Mediterranean Journal of Rheumatology, 34(4), 404–413. https://doi.org/10.31138/mjr.301223.eaf
  98. Verhaar, J. A. N., Kjærsgaard-Andersen, P., Limb, D., Günther, K. P., & Karachalios, T. (Eds.). (2021). The EFORT White Book: “Orthopaedics and Traumatology in Europe”. Dennis Barber Ltd.
  99. Wei, L., Chen, X., & Liu, M. (2025). Global, regional, and national burden and trends of rheumatoid arthritis among the elderly population: an analysis based on the 2021 Global Burden of Disease study. Frontiers in Immunology, 16, 1547763. https://doi.org/10.3389/fimmu.2025.1547763
  100. World Health Organization. (2023). Rheumatoid arthritis fact sheet. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/rheumatoid-arthritis (on June 22, 2025).
  101. Wu, F., Gao, J., Kang, J., Wang, X., Niu, Q., Liu, J., & Zhang, L. (2021). B Cells in Rheumatoid Arthritis：Pathogenic Mechanisms and Treatment Prospects. Frontiers in Immunology, 12, 750753. https://doi.org/10.3389/fimmu.2021.750753
  102. Wysocki, T., Olesińska, M., & Paradowska-Gorycka, A. (2020). Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis-From Research to Clinical Practice. Cells, 9(5), 1127. https://doi.org/10.3390/cells9051127
  103. Xi, M., Ruan, Q., Zhong, S., Li, J., Qi, W., Xie, C., Wang, X., Abuduxiku, N., & Ni, J. (2024). Periodontal bacteria influence systemic diseases through the gut microbiota. Frontiers in Cellular and Infection Microbiology, 14, 1478362. https://doi.org/10.3389/fcimb.2024.1478362
  104. Yang, M. L., Sodré, F. M. C., Mamula, M. J., & Overbergh, L. (2021). Citrullination and PAD Enzyme Biology in Type 1 Diabetes – Regulators of Inflammation, Autoimmunity, and Pathology. Frontiers in Immunology, 12, 678953. https://doi.org/10.3389/fimmu.2021.678953
  105. Yang, M., & Zhu, L. (2024). Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis. International Journal of Molecular Sciences, 25(5), 2688. https://doi.org/10.3390/ijms25052688
  106. Yaseen, K., & Mandell, B.F. (2025). Rheumatoid Arthritis (RA). Retrieved from:

https://www.msdmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/joint-disorders/rheumatoid-arthritis-ra (on June 22, 2025).

  1. Young, A., & Koduri, G. (2007). Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology, 21(5), 907–927. https://doi.org/10.1016/j.berh.2007.05.007
  2. Zhou, P., Zheng, T., & Zhao, B. (2022). Cytokine-mediated immunomodulation of osteoclastogenesis. Bone, 164, 116540. https://doi.org/10.1016/j.bone.2022.116540

How to Cite :

Immunopathology and Laboratory Diagnosis of Rheumatoid Arthritis: A Review of Literature. Erhunmwunse RU, Chukwu RJ, Ehiaghe FA, Ogbodo EC, 8(7), 3231-3245. Retrieved from https://ijcsrr.org/single-view/?id=23265&pid=23201

Most read articles by the same author(s)

Erhunmwunse RU, Chukwu RJ, Ehiaghe FA, Ogbodo EC,

View

224

Citation

Downloads

Article Details